Retraction of “Universal theranostic CRISPR/Cas13a RNA-editing system for glioma”

Wu, Ye; Wang, Yunfei; Zhou, Junhu; Wang, Jianhao; Zhan, Qi; Wang, Qixue; Yang, Eryan; Jin, Weili; Tong, Fei; Zhao, Jixing; Hong, Biao; Liu, Junrui; Kang, Chunsheng

doi:10.7150/thno.96658



Nanotheranostics 2024; 8(4): 442-457. [Abstract] [Full text] [PDF]

Nanotheranostics 2024; 8(4): 427-441. [Abstract] [Full text] [PDF]

Nanotheranostics

International Journal of Biological Sciences

International Journal of Medical Sciences

Journal of Cancer

Global reach, higher impact

Full Text | PDF

Theranostics 2024; 14(6):2489. doi:10.7150/thno.96658 This issue Cite

Retraction

Retraction of “Universal theranostic CRISPR/Cas13a RNA-editing system for glioma”

Ye Wu^1,2,*, Yunfei Wang^1,*, Junhu Zhou^1,*, Jianhao Wang¹, Qi Zhan³, Qixue Wang¹, Eryan Yang¹, Weili Jin¹, Fei Tong¹, Jixing Zhao¹, Biao Hong¹, Junrui Liu⁴, Chunsheng Kang^1✉

1. Tianjin Neurological Institute, Tianjin Medical University General Hospital, Key Laboratory of Post-neurotrauma Neuro-repair and Regeneration in Central Nervous System, Ministry of Education, Tianjin City, Tianjin 300052, China.
2. Department of Dermatovenereology, Tianjin Medical University General Hospital, Tianjin 300052, China.
3. Tianjin Key Laboratory of Composite and Functional Materials, School of Materials Science and Engineering, Tianjin University, Tianjin, China.
4. College of Pharmacy, Kunming Medical University, Yunnan, China.
* These authors contributed equally to this work.

Citation:

Wu Y, Wang Y, Zhou J, Wang J, Zhan Q, Wang Q, Yang E, Jin W, Tong F, Zhao J, Hong B, Liu J, Kang C. Retraction of “Universal theranostic CRISPR/Cas13a RNA-editing system for glioma”. Theranostics 2024; 14(6):2489. doi:10.7150/thno.96658. https://www.thno.org/v14p2489.htm

Other styles

Retracted-article in Theranostics, Volume 13, 5305

Citation styles

APA

Wu, Y., Wang, Y., Zhou, J., Wang, J., Zhan, Q., Wang, Q., Yang, E., Jin, W., Tong, F., Zhao, J., Hong, B., Liu, J., Kang, C. (2024). Retraction of “Universal theranostic CRISPR/Cas13a RNA-editing system for glioma”. Theranostics, 14(6), 2489. https://doi.org/10.7150/thno.96658.

ACS

Wu, Y.; Wang, Y.; Zhou, J.; Wang, J.; Zhan, Q.; Wang, Q.; Yang, E.; Jin, W.; Tong, F.; Zhao, J.; Hong, B.; Liu, J.; Kang, C. Retraction of “Universal theranostic CRISPR/Cas13a RNA-editing system for glioma”. Theranostics 2024, 14 (6), 2489. DOI: 10.7150/thno.96658.

NLM

CSE

Wu Y, Wang Y, Zhou J, Wang J, Zhan Q, Wang Q, Yang E, Jin W, Tong F, Zhao J, Hong B, Liu J, Kang C. 2024. Retraction of “Universal theranostic CRISPR/Cas13a RNA-editing system for glioma”. Theranostics. 14(6):2489.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.